Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Janssen to start phase III trial of daratumumab in multiple myeloma in Q4 2014 Genmab partner Janssen Biotech (Janssen) is planning to start a new phase III trial of daratumumab for the treatment of patients with multiple myeloma during the fourth quarter of 2014. Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Auxilium Pharmaceuticals achieves positive results from phase 2a study of CCH in patients with cellulite
By PBR Staff Writer
Auxilium Pharmaceuticals announced positive results from a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum (or CCH) for the treatment of edematous fibrosclerotic panniculopathy (EFP), commonly known as cellulite.
Contract Research & Services > Clinical Trials > News
Pfizer initiates EAP for palbociclib in US
By PBR Staff Writer
Pfizer Inc. announced that the company has initiated a multi-center, open-label expanded access program (EAP) in the United States for the investigational CDK 4/6 inhibitor, palbociclib.
Contract Research & Services > Clinical Trials > News

Contract Research

UK launches emergency research to help battle Ebola outburst
By PBR Staff Writer
The UK Department for International Development (DIFD) and the Wellcome Trust health research charity have offered experts £6.5m to find ways to save the lives of citizens hit with the Ebola virus.
Contract Research & Services > Contract Research > News
Recipharm to buy Corvette Pharmaceutical Services for $160m
By PBR Staff Writer
Swedish contract development and manufacturing organisation Recipharm has agreed to purchase Milan based Corvette Pharmaceutical Services Group (Corvette) from Italian private equity group LBO Italia Investimenti.
Contract Research & Services > Contract Research > News

Contract Services

Lannett agrees to purchase two generic pharmaceutical products
By PBR Staff Writer
Lannett has signed an agreement to acquire abbreviated new drug applications (ANDAs) for two generic pharmaceutical products.
Contract Research & Services > Contract Services > News